Loading...
Sanofi
SNW.DE•XETRA
HealthcareDrug Manufacturers - General
€88.43
€0.95(1.09%)
Sanofi (SNW.DE) Financial Performance & Statements
Review Sanofi’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-3.80%
↓ 3.80%
Operating Income Growth
-7.91%
↓ 7.91%
Net Income Growth
2.96%
↑ 2.96%
Operating Cash Flow Growth
-11.47%
↓ 11.47%
Operating Margin
18.55%
↑ 18.55%
Gross Margin
71.13%
↑ 71.13%
Net Profit Margin
14.39%
↑ 14.39%
ROE
8.48%
↑ 8.48%
ROIC
8.15%
↑ 8.15%
Sanofi (SNW.DE) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Sanofi stock.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $7.63B | $14.16B | $11.38B | $11.12B |
Cost of Revenue | $2.27B | $4.08B | $3.39B | $3.44B |
Gross Profit | $5.36B | $10.07B | $7.99B | $7.68B |
Gross Profit Ratio | $0.70 | $0.71 | $0.70 | $0.69 |
R&D Expenses | $2.12B | $1.85B | $1.72B | $1.72B |
SG&A Expenses | $1.24B | $2.68B | $2.69B | $2.60B |
Operating Expenses | $4.79B | $6.44B | $6.63B | $6.27B |
Total Costs & Expenses | $7.06B | $10.52B | $10.02B | $9.71B |
Interest Income | $0.00 | $133.00M | $56.00M | $102.00M |
Interest Expense | $0.00 | $265.00M | $135.00M | $253.00M |
Depreciation & Amortization | $209.00M | $479.00M | $882.00M | $829.50M |
EBITDA | $563.00M | $4.25B | $2.51B | $2.86B |
EBITDA Ratio | $0.07 | $0.30 | $0.22 | $0.26 |
Operating Income | $573.00M | $3.63B | $1.63B | $2.03B |
Operating Income Ratio | $0.08 | $0.26 | $0.14 | $0.18 |
Other Income/Expenses (Net) | -$117.00M | -$132.00M | -$179.00M | -$139.00M |
Income Before Tax | $456.00M | $3.50B | $1.42B | $1.31B |
Income Before Tax Ratio | $0.06 | $0.25 | $0.12 | $0.12 |
Income Tax Expense | $4.00M | $737.00M | $299.00M | $164.00M |
Net Income | $499.00M | $2.81B | $1.11B | $1.13B |
Net Income Ratio | $0.07 | $0.20 | $0.10 | $0.10 |
EPS | $0.40 | $2.25 | $0.89 | $0.91 |
Diluted EPS | $0.40 | $2.25 | $0.88 | $0.91 |
Weighted Avg Shares Outstanding | $986.42M | $1.25B | $1.25B | $1.25B |
Weighted Avg Shares Outstanding (Diluted) | $1.26B | $1.25B | $1.25B | $1.25B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan